Fate Therapeutics, Inc. (NASDAQ: FATE) Stock Information | RedChip

Fate Therapeutics, Inc. (NASDAQ: FATE)


$1.7400
-0.0100 ( -2.41% ) 16.4K

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Market Data


Open


$1.7400

Previous close


$1.7500

Volume


16.4K

Market cap


$199.32M

Day range


$1.7460 - $1.9050

52 week range


$1.5500 - $8.8300

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Jul 31, 2024
4 Insider transactions 1 Jul 31, 2024
4 Insider transactions 1 Jul 31, 2024
4 Insider transactions 1 Jul 31, 2024
3 Insider transactions 2 Jul 31, 2024
4 Insider transactions 1 Jun 11, 2024
4 Insider transactions 1 Jun 11, 2024
def Proxies and info statements 20 Apr 26, 2024
ars Annual reports 1 Apr 26, 2024

Latest News